SP Tulsian of sptulsian.com feels that Wockhardt may go above Rs 1000 in next 18-24 months.

Bullish on Lupin, Aurobindo; cautious on Ranbaxy: Religare

Arvind Bothra, vice president of institutional research at Religare Capital Markets is cautious on Ranbaxy because the earnings visibility is very low and believes that the expectations of a turnaround in the US business etc are seemingly priced-in the stock.

Prefer Wockhardt, says Dilip Bhat

Dilip Bhat of Prabhudas Lilladher is of the view that one may look at buying Wockhardt.

Wockhardt may rise by 12-15%, says Rahul Mohindar

Rahul Mohindar of viratechindia.com is of the view that Wockhardt may rise by 12-15 percent in the next one month.

Wockhardt may slip to Rs 340-360: Shardul Kulkarni

According to Shardul Kulkarni of Angel Broking, one may see Wockhardt falling towards Rs 340-360 levels.

Sudarshan Sukhani bearish on Wockhardt

Sudarshan Sukhani of s2analytics.com has a bearish stance on Wockhardt. "This is not a buy on dips opportunity, it is something much worse," he adds.

Sell Wockhardt on rally: Mayuresh Joshi

Mayuresh Joshi of Angel Broking advises selling Wockhardt on rallies.

Buy Sun Pharma, Dr Reddy's Labs, Lupin: Baliga

Ambareesh Baliga of Edelweiss Financial Services advises to prefer Sun Pharmaceutical Industries, Dr Reddys Laboratories and Lupin from the pharma space.

Avoid Wockhardt, advises Nitin Jain

Nitin Jain of Edelweiss Securities is of the view that one may avoid Wockhardt.

Exit Wockhardt, advises Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends exiting Wockhardt and advises switching to Lupin or Dr Reddys Laboratories.

Resistance for Wockhardt at Rs 580- Rs 590: SP Tulsian

According to SP Tulsian of sptulsian.com, Wockhardt may trade in the range of Rs 500 and may face resistance at 580-590.

Hold Wockhardt for target of Rs 700: Vishal Malkan

Vishal Malkan, CMT at www.malkansview.com is of the view that one may hold Wockhardt with a target of Rs 700.

Hold Wockhardt, says Phani Sekhar

Phani Sekhar, Fund Manager at Angel Broking suggests holding Wockhardt.

Exit Wockhardt on rallies: Mayuresh Joshi

Mayuresh Joshi of Angel Broking is of the view that one may exit Wockhardt on rallies.

Wockhardt may stabilise around Rs 500: SP Tulsian

SP Tulsian of sptulsian.com is of the view that Wockhardt may stabilise at around a level of Rs 500.

Lupin may touch Rs 885-890, says SP Tulsian

According to SP Tulsian of sptulsian.com, Lupin may touch Rs 885-890. “The company received the USFDA approval for launch of the generic version of the Sanofi‘s Ambien, which is for curing of insomnia and it has USD 400 million markets,” he adds.

Buy Wockhardt at Rs 600, says SP Tulsian

SP Tulsian of sptulsian.com is of the view that Wockhardt can correct to a level of Rs 600 in the near term; in the next one week or so wherein one should look to buy it.

Below Rs 645, Wockhardt may test Rs 550-525: Kulkarni

Shardul Kulkarni of Angel Broking is of the view that Wockhardt may test Rs 550-525 if the stock falls below Rs 645. "One may place stoploss at Rs 645," he adds.

Buy Wockhardt, Hexaware Tech; sell Allahabad Bank: Joshi

Sharmila Joshi of Peerless Securities recommends buying Wockhardt with a target of Rs 470 and advises selling Voltas with a stop loss at Rs 70.70.

Bull's Eye: Buy Hexaware, Wockhardt; short Financial Tech

Prakash Diwan of Altamount Capital Management advised buying Jet Airways with a target price of Rs 328.50 and Hexaware Technologies with a target price of Rs 124.90.

Pick Wockhardt, says SP Tulsian

According to SP Tulsian of sptulsian.com, one may pick Wockhardt.

Hold Wockhardt, says Shardul Kulkarni

According to Shardul Kulkarni of Angel Broking, one may hold on to Wockhardt till Rs 750 and then book profits.

Sell Wockhardt, says Mayuresh Joshi

Mayuresh Joshi, VP Institution of Angel Broking is of the view that one may sell Wockhardt and look at Lupin or Dr Reddys Laboratories which posted a good set of numbers within the pharma space.

Sell Wockhardt: Jagannadham Thununguntla

if one is looking for short to medium-term one should exit Wockhardt, says Jagannadham Thununguntla, Strategist & Head of Research of SMC Global Securities.

Stay away from Wockhardt, says Rakesh Arora

Rakesh Arora, HOR, India at Macquarie Capital Securities recommends to stay away from Wockhardt.